Symposia: Outcomes Research—Non-Malignant Conditions
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Bleeding and Clotting, bleeding disorders, Anticoagulant Drugs, clinical trials, adult, Non-Biological therapies, Clinical Practice (Health Services and Quality), hemophilia, epidemiology, Clinical Research, health outcomes research, Combination therapy, Genetic Disorders, Diversity, Equity, and Inclusion (DEI) , thromboembolism, Diseases, thrombocytopenias, Immune Disorders, patient-reported outcomes, Therapies, Adverse Events, Pharmacology, survivorship, Surgical, Study Population, Human
Type: Oral
Hematology Disease Topics & Pathways:
Research, Bleeding and Clotting, bleeding disorders, Anticoagulant Drugs, clinical trials, adult, Non-Biological therapies, Clinical Practice (Health Services and Quality), hemophilia, epidemiology, Clinical Research, health outcomes research, Combination therapy, Genetic Disorders, Diversity, Equity, and Inclusion (DEI) , thromboembolism, Diseases, thrombocytopenias, Immune Disorders, patient-reported outcomes, Therapies, Adverse Events, Pharmacology, survivorship, Surgical, Study Population, Human
Sunday, December 11, 2022: 9:30 AM-11:00 AM
295-296
(Ernest N. Morial Convention Center)
Moderators:
Ang Li, MD, MS, Baylor College of Medicine
and
Anna L Parks, MD, University of Utah
Disclosures:
No relevant conflicts of interest to declare.
This session will review treatment outcomes in rare hematologic conditions including aplastic anemia, thromobocytopenia and pyruvate kinase deficiency
9:30 AM
9:45 AM
10:15 AM
10:30 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH